Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009
- Conditions
- Respiratory Syncyctial Virus Vaccines
- Interventions
- Other: Data collection
- Registration Number
- NCT01706302
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
The study will assess the burden of RSV-attributable general practice consultations, hosptializations, and deaths by age and risk group in in United Kingdom from 1995 to 2009.
- Detailed Description
This epidemiological study is based on an already existing database of time series regression modeling outputs generated during the generated by EPI-FLU-018 BOD UK DB (116273) study, which estimated the burden of influenza in terms of General Practitioner (GP) consultations, hospitalizations, and deaths associated with various respiratory and non-respiratory outcomes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1
• Included in the EPI-FLU-018 BOD UK DB BOD UK DB (eTrack: 116273) study database. The inclusion criterion for EPI-FLU-018 was registration with an acceptable flag in the CPRD, or registration in the HES database or the ONS mortality data with a flu-related event.
• Not Applicable
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Cohort Group Data collection -
- Primary Outcome Measures
Name Time Method Occurrence in the EPI-FLU-018 BOD UK DB results database of potentially RSV-attributable GP consultation, hospitalization or death associated with respiratory outcomes. From 1995 to 2009
- Secondary Outcome Measures
Name Time Method Occurrence in the EPI-FLU-018 BOD UK DB results database of potentially RSV-attributable GP consultation, hospitalization or death associated with non-respiratory outcomes. From 1995 to 2009 Occurrence in the EPI-FLU-018 BOD UK DB results database of potentially RSV-attributable GP prescription of antibiotics relevant to respiratory disease, by age and risk group. From 1995 to 2009 Peak occurrence of potentially RSV-attributable hospitalizations and deaths in elderly and pediatric populations. From 1995 to 2009 Occurrence of potentially RSV-attributable deaths among the total number of RSV-attributable hospitalizations and cases, by age and risk group. From 1995 to 2009